CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment)
Sponsor
Hôpital Edouard Herriot (Other)
Overall Status
Completed
CT.gov ID
NCT03455595
Collaborator
(none)
60
1
12
5
Study Details
Study Description
Brief Summary
Prospective study so as to evaluate CONECCT score to determine both histological tissue and therapeutic choice
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
60 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
CONECCT Score so as to Improve the Diagnosis and the Treatment of Colorectal Neoplasia
Actual Study Start Date
:
Feb 1, 2017
Actual Primary Completion Date
:
Feb 1, 2018
Actual Study Completion Date
:
Feb 1, 2018
Outcome Measures
Primary Outcome Measures
- Evaluation of the CONECCT endoscopic score so as to improve colon therapeutic treatment polyps [one year]
There are recognized diagnostic criteria so as to predict the histology of colorectal lesions and thus to choose the right therapy. For the moment, these criteria are scattered in at least 5 different classifications and the CONECCT tool will allow gastroenterology interns to more easily predict the histology of the lesion and so to improve the management of them.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- N/A
Exclusion Criteria:
- N/A
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Edouard Herriot Hospital | Lyon | Rhône Alpes | France | 69437 |
Sponsors and Collaborators
- Hôpital Edouard Herriot
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Jean Christophe Saurin,
Professor,
Hôpital Edouard Herriot
ClinicalTrials.gov Identifier:
NCT03455595
Other Study ID Numbers:
- CONECCT
First Posted:
Mar 6, 2018
Last Update Posted:
Mar 12, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: